Status:
COMPLETED
Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases
Lead Sponsor:
University Hospital, Ghent
Conditions:
Bone Metastases
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
In various common cancers, the skeleton is a preferred site of metastasis. These bone metastases are the most common cause of cancer-related pain, which significantly impair quality of life. It is pos...
Eligibility Criteria
Inclusion
- Painful bone metastasis of solid tumors
- Pain score minimum of 2 on a scale of 10
- A maximum number of painful bone metastases: 3 or more
- Life expectancy \> 3 months
- Age minimum 18 years old
- Signed informed consent
Exclusion
- Tumor histology (renal cell and melanoma vs. other solid tumors)
- VAS pain score (\<5 vs. 6-10).
- Bisphosphonate use (yes vs. no)
- Opioid analgesics (yes vs. no)
- Corticosteroid use (yes vs. no)
- Spine vs non-spine localisation
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT01429493
Start Date
February 1 2013
End Date
December 1 2015
Last Update
December 16 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Antwerp
Antwerp, Belgium
2
Ghent University Hospital
Ghent, Belgium, 9000